Paul M. Haste, MD

Bio

Dr. Paul Haste is an interventional radiologist, focusing his career predominantly on the treatment of primary and secondary liver cancer. He currently serves as a Vice Chair in the Department of Radiology, overseeing all procedural radiology. He also serves as the division chief of interventional radiology for the department, overseeing the division’s work throughout the state.

He completed his undergraduate degree from Indiana State University in 2007. He then attended and Indiana University School of Medicine, graduating in 2011. He then went on to complete a diagnostic radiology residency at Indiana University, and completed his subspecialty interventional radiology training at the University of California-San Francisco in 2017. He has been an interventional radiology faculty member here at IU since the completion of his training.

Throughout his career he has focused strongly on interventional oncology and is a member of the IU Simon Cancer Center. He has contributed heavily to multiple different tumor boards here at IU throughout his career and has worked extensively on local, national, and international multidisciplinary research efforts to improve the treatment of patients with both primary and metastatic liver cancer. Spending most of his clinical time at IU Health’s University Hospital, he also has a strong clinical interest and expertise in all hepatobiliary, post-transplant and portal hypertension interventions.

Key Publications

1. Haste P, Tann M, Persohn S, LaRoche T, Aaron V, Mauxion T, et al. Correlation of Technetium-99m Macroaggregated Albumin and Yttrium-90 Glass Microsphere Biodistribution in Hepatocellular Carcinoma: A Retrospective Review of Pretreatment Single Photon Emission CT and Posttreatment Positron Emission Tomography/CT. Journal of Vascular and Interventional Radiology. 2017 May;28(5):722–730.e1.

2.  Miller M, Sze D, Padia S, Lewandowski R, Salem R, Mpofu P, Haste P, Johnson M. Response and Overall Survival for Yttrium-90 Radioembolization of Hepatic Sarcoma: A Multicenter Retrospective Study.  Journal of Vascular and Interventional Radiology. 2018 June;29(6): 867 - 873

3. Schmitz A*, Haste P, Johnson MS. Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation Prior to Abdominal Operation: a Retrospective Analysis. Journal of Gastrointestinal Surgery. 2019 September

4. Rice M^*, Krosin M, Haste P. Post Yttrium-90 Imaging. Semin Intervent Radiol. 2021 Oct;38(4):460-465. doi: 10.1055/s-0041-1735569. Epub 2021 Oct 7. PMID: 34629714; PMCID: PMC8497086

5. Lam, M., Garin, E., Maccauro, M., Kappadath, S. C., Sze, D. Y., Turkmen, C., Cantasdemir, M., Haste, P. , Herrmann, K., Alsuhaibani, H. S., Dreher, M., Fowers, K. D., Salem, R. (2022). A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study. European journal of nuclear medicine and molecular imaging.

6. Salem R, Padia SA, Lam M, Chiesa C, Haste P, Sangro B, Toskich B, Fowers K, Herman JM,Kappadath SC, Leung T, Sze DY, Kim E, Garin E. Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group. Eur J Nucl Med Mol Imaging. 2022 Sep 17. doi: 10.1007/s00259-022-05956-w

7. Lam M, Garin E, Palard-Novello X, Mahvash A, Kappadath C, Haste P, Tann M, Herrmann K, Barbato F, Geller B, Schaefer N, Denys A, Dreher M, Fowers KD, Gates V, Salem R. Direct comparison and reproducibility of two segmentation methods for multicompartment dosimetry: round robin study on radioembolization treatment planning in hepatocellular carcinoma. Eur J Nucl Med Mol Imaging. 2023 Sep 12. doi: 10.1007/s00259-023-06416-9. Epub ahead of print. PMID: 37698645.

8. Benson AB III, Venook AP, Adam M, et al. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Colon Cancer. Version 3.2024. J Natl Compr Canc Netw 2024;22(2D):e240029. doi:10.6004/jnccn.2024.0029